Plavix is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bristol-myers Squibb/sanofi Pharmaceuticals Partnership. The primary component is Clopidogrel Bisulfate.
| Product ID | 63653-1332_12eb3088-f30b-4bb5-aee0-113114b5a08c |
| NDC | 63653-1332 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Plavix |
| Generic Name | Clopidogrel |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-05-09 |
| Marketing End Date | 2022-07-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020839 |
| Labeler Name | Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership |
| Substance Name | CLOPIDOGREL BISULFATE |
| Active Ingredient Strength | 300 mg/1 |
| Pharm Classes | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2009-05-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-05-09 |
| Marketing End Date | 2020-05-31 |
| Marketing Category | NDA |
| Application Number | NDA020839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-05-09 |
| Marketing End Date | 2009-11-30 |
| Ingredient | Strength |
|---|---|
| CLOPIDOGREL BISULFATE | 300 mg/1 |
| SPL SET ID: | 01b14603-8f29-4fa3-8d7e-9d523f802e0b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0024-1171 | Plavix | clopidogrel |
| 0024-1332 | Plavix | clopidogrel |
| 21695-665 | Plavix | clopidogrel bisulfate |
| 53808-0763 | Plavix | Plavix |
| 55289-911 | Plavix | Plavix |
| 63653-1332 | Plavix | Plavix |
| 63653-1171 | Plavix | Plavix |
| 67046-604 | Plavix | Plavix |
| 0093-7314 | Clopidogrel | Clopidogrel |
| 0615-7719 | Clopidogrel | Clopidogrel |
| 16714-052 | Clopidogrel | Clopidogrel |
| 16729-218 | Clopidogrel | Clopidogrel |
| 16729-219 | Clopidogrel | Clopidogrel |
| 31722-901 | clopidogrel | clopidogrel |
| 31722-902 | clopidogrel | clopidogrel |
| 33342-060 | Clopidogrel | Clopidogrel |
| 42543-713 | Clopidogrel | clopidogrel |
| 42543-714 | Clopidogrel | clopidogrel |
| 43547-484 | CLOPIDOGREL | clopidogrel |
| 43547-485 | CLOPIDOGREL | clopidogrel |
| 50090-4918 | Clopidogrel | Clopidogrel |
| 50090-5781 | Clopidogrel | Clopidogrel |
| 52605-082 | clopidogrel | clopidogrel |
| 0378-3627 | Clopidogrel Bisulfate | clopidogrel |
| 51079-558 | Clopidogrel Bisulfate | clopidogrel |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PLAVIX 90168789 not registered Live/Pending |
Sanofi 2020-09-09 |
![]() PLAVIX 75443638 2320230 Live/Registered |
SANOFI 1998-03-03 |
![]() PLAVIX 75438881 2380297 Live/Registered |
SANOFI 1998-02-23 |
![]() PLAVIX 74482767 2042583 Live/Registered |
SANOFI 1994-01-26 |